76 related articles for article (PubMed ID: 3097469)
1. [Molsidomine in rest and exercise conditions in coronary heart disease. Acute and long-term effects].
Jansen W; Meyer L; Osterspey A; Eggeling T; Tauchert M; Hilger HH
Med Klin (Munich); 1986 Jun; 81(14):489-95. PubMed ID: 3097469
[No Abstract] [Full Text] [Related]
2. [Acute and long-term effects of placebo and molsidomine on pulmonary artery pressure and on workload in patients with coronary heart disease].
Jansen W; Osterspey A; Schell U; Tauchert M
Schweiz Rundsch Med Prax; 1986 Oct; 75(41):1210-4. PubMed ID: 3787007
[No Abstract] [Full Text] [Related]
3. Acute and chronic effects of molsidomine on pulmonary artery pressure and work capacity in patients with coronary heart disease.
Jansen W; Eggeling T; Meyer L; Tauchert M; Hilger HH
Eur Heart J; 1987 Aug; 8(8):870-7. PubMed ID: 3665944
[TBL] [Abstract][Full Text] [Related]
4. [Hemodynamic effect of molsidomine in coronary patients with heart failure with clinically manifest nitrate tolerance].
Störk T; Möckel M; Störk S; Piske G; Danne O; Bodemann T; Müller R; Eichstädt H; Hochrein H
Z Kardiol; 1993 May; 82(5):293-301. PubMed ID: 8328179
[TBL] [Abstract][Full Text] [Related]
5. Effects of long-term molsidomine treatment versus isosorbide dinitrate and placebo on exercise tolerance in stable angina.
Romano M; de Caprio L; Meccariello P; Cuomo S; Baldini F; D'Ascia C; Steinberg G; Chiariello M
Int J Clin Pharmacol Ther Toxicol; 1984 May; 22(5):246-9. PubMed ID: 6430811
[TBL] [Abstract][Full Text] [Related]
6. [Hemodynamic effect of molsidomine in acute administration and as a long-term medication].
Osterspey A; Jansen W; Tauchert M; Schell U; Fuchs M; Hombach V; Hilger HH
Med Welt; 1983 Apr; 34(17):523-8. PubMed ID: 6408341
[No Abstract] [Full Text] [Related]
7. [Problems in long-term therapy of coronary heart disease: pharmacotherapy].
Gilfrich HJ
Med Klin (Munich); 1987 Jan; 1():29-32. PubMed ID: 3106752
[No Abstract] [Full Text] [Related]
8. Long-term treatment of patients with coronary heart disease using isosorbide dinitrate, nifedipine and molsidomine.
Jansen W; Tauchert M; Osterspey A; Hombach V; Fuchs M; Hilger HH
Z Kardiol; 1983; 72 Suppl 3():203-10. PubMed ID: 6689389
[TBL] [Abstract][Full Text] [Related]
9. [The importance of Lopion (molsidomine) in the therapy of myocardial ischemia and angina pectoris].
Trifunović S; Pavlović K
Med Pregl; 1987; 40(1-2):17-21. PubMed ID: 3657717
[No Abstract] [Full Text] [Related]
10. [Treatment of stress-induced angina pectoris and chronic heart failure with molsidomine].
Beyerle A; Rudolph W
Med Klin (Munich); 1986 Jan; 81(2):41-4. PubMed ID: 3537664
[No Abstract] [Full Text] [Related]
11. [Therapeutic effectiveness of molsidomine in patients with exercise-induced angina pectoris].
Sinkiewicz W; Dziedziczko A
Pol Tyg Lek; 1993 Jan 18-25; 48(3-4):80-2. PubMed ID: 8361895
[TBL] [Abstract][Full Text] [Related]
12. [Problems in acute therapy of coronary heart disease using drugs that reduce preload and afterload].
Krüger R
Med Klin (Munich); 1987 Jan; 1():19-23. PubMed ID: 3106750
[No Abstract] [Full Text] [Related]
13. Acute hemodynamic effects of molsidomine in patients with ischemic cardiomyopathy.
Caralis DG; Kyriakides Z; Ioakimides C
Cardiovasc Drugs Ther; 1991 Feb; 5(1):155-6. PubMed ID: 2036334
[No Abstract] [Full Text] [Related]
14. [Molsidomine and isosorbide dinitrate: a comparative trial of tolerance in long-term intake by IHD patients with stable angina of effort].
Alimova EV; Martsevich SIu; Kutishenko NP; Metelitsa VI
Ter Arkh; 1997; 69(12):37-40. PubMed ID: 9503532
[TBL] [Abstract][Full Text] [Related]
15. [Long-term antihypertensive effect of delayed-action molsidomine].
Fach WA; Kostanecka T; Kober G
Z Kardiol; 1994 Sep; 83(9):646-51. PubMed ID: 7801667
[TBL] [Abstract][Full Text] [Related]
16. [Effects of molsidomine during the cold test in stable coronary insufficiency under beta-blocker treatment].
Zygelman M; Neukirch F; Mérillon JP; Dahan M; Trouillet JL; Juliard JM; Pansard Y; Gourgon R
Arch Mal Coeur Vaiss; 1984 Nov; 77(12):1383-9. PubMed ID: 6150693
[TBL] [Abstract][Full Text] [Related]
17. [Evaluation of the clinical usefulness of molsidomine in ischemic heart disease].
Janicki K; Ochmański W; Kmieć M
Pol Tyg Lek; 1986 Jun 23-30; 41(25-26):829-34. PubMed ID: 3534821
[No Abstract] [Full Text] [Related]
18. [The effect of molsidomine preparations on the coronary and myocardial reserves of patients with IHD complicated by circulatory failure].
Ol'binskaia LI; Sizova ZhM; Alekperov EE
Ter Arkh; 1994; 66(8):30-2. PubMed ID: 7985149
[TBL] [Abstract][Full Text] [Related]
19. Hemodynamic effects of molsidomine on weight sustaining isometric exercise in patients with ischemic heart disease.
Tsujibayashi T; Niwa A; Taniguchi K; Takeuchi J
Bull Tokyo Med Dent Univ; 1985 Dec; 32(4):163-7. PubMed ID: 3865742
[TBL] [Abstract][Full Text] [Related]
20. Differences in the antiischaemic effects of molsidomine and isosorbide dinitrate.
Jost S
Eur Heart J; 1992 May; 13(5):720. PubMed ID: 1618218
[No Abstract] [Full Text] [Related]
[Next] [New Search]
